Screening and Early Detection
636 articles
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Tailoring My Treatment to My Tumor Genetics
After diagnosis with pancreatic cancer, Sharon Simone had her tumor analyzed. The report on her tumor genetics determined her treatment.
Chemotherapy to Survive; Fitness to Thrive
Mike Levine switched oncologists to find chemotherapy that works on his pancreatic cancer. After that he was able to compete in the Ironman Triathlon.
Why ME?
Harry Sparks went for a second opinion after he was diagnosed with pancreatic cancer, and was able to have Whipple surgery.
Nutrition Myths Debunked
Does sugar really feed cancer? Is a keto diet better for cancer? Should cancer patients avoid fats? Dietitians L.J. Amaral and Jessica Harrison take on common nutrition myths.
A Look Back at Research in 2024
Research in 2024 focused on personally tailored treatments, countering the most difficult effects of pancreatic cancer, and clinical trials.
Diagnosed with Pancreatic Cancer? Partner with a Registered Dietitian
Audrey Caspar-Clark, a registered dietitian specializing in pancreatic cancer, provides tips on finding the right nutritional help.
Targeting Cancer Metabolism
Researchers from Tyme Technologies are focusing on cancer cell metabolism, particularly tyrosine, as a way to kill cancer cells.
An Exemplary Life: The PR Lessons Anne Glauber Left Us
A tribute to the life, works, and pancreatic cancer treatment education mission of Anne Glauber, founder of Let’s Win, by Seth Arenstein.
Climbing the Pancreatic Cancer Mountain
Kenneth Brown got second and third opinions before he chose a treatment plan that included neoadjuvant chemotherapy and a Whipple procedure.
Solving the Mystery of Cachexia
Researchers are looking for ways to combat cachexia, the metabolic syndrome that causes weight and muscle loss in people with cancer and other diseases.
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
Researching More Second-Line Options for Pancreatic Cancer
Dr. Allyson Ocean explains the concept behind a novel second-line treatment being tested for metastatic pancreatic cancer.
Complementary Therapies—a Way to Gain Peace?
What techniques are other pancreatic cancer patients using to relieve symptoms and side effects, and cope with treatment? Learn more about the most popular complementary therapies.
With No Family History of Cancer, Surprised By the Diagnosis
Marianne, a nurse, went to a hospital that specializes in cancer. A liquid biopsy will determine the next step in her treatment.